Amiodarone HCL Injection 150mg/ 3 mL Single Dose Vials 3 mL x 10/Box (Rx)

Amiodarone Hydrochloride Injection 150mg/3 mL Single Dose Vials is a medication used to treat certain heart rhythm disorders, also known as arrhythmias. It is given as an injection into a vein by a healthcare provider and contains the active ingredient amiodarone hydrochloride. The vials come in a single dose of 150mg/3mL and are used to provide a specific amount of the medication for each patient. This medication is only available through a prescription from a doctor and should be used under medical supervision.

Rapid, Life-Saving Arrhythmia Control: Amiodarone HCl Injection 150 mg/3 mL by Mylan

When every second counts for patients experiencing life-threatening cardiac arrhythmias, trust Amiodarone HCl Injection 150 mg/3 mL from Mylan (NDC: 67457-0153-03). This hospital-standard, single-dose IV formulation offers reliable, fast-acting antiarrhythmic action that is indispensable in emergency and acute care settings. Each box includes 10 convenient 3 mL vials, ensuring rapid access to this essential medication whenever it is needed most.

Uses

• Treatment of Ventricular Fibrillation (VF): First-line therapy for patients unresponsive to defibrillation or other interventions.
• Ventricular Tachycardia (VT): Acute management of hemodynamically unstable, recurrent ventricular tachycardia.
• Advanced Cardiac Life Support (ACLS): Integral to protocols for advanced cardiac resuscitation and rhythm stabilization.

Benefits

• Rapid-Acting IV Therapy: Delivers immediate antiarrhythmic effects for life-threatening heart rhythms.
• Broad-Spectrum Action: Effective on both atrial and ventricular arrhythmias, making it a versatile cardiac emergency drug.
• Single-Dose Convenience: Pre-measured 3 mL vials reduce dosing errors and facilitate fast preparation.
• Hospital-Grade Quality: Manufactured by Mylan—trusted for consistency, sterility, and efficacy in critical care.
• Cost-Effective Multi-Vial Box: Contains 10 single-use vials; perfect for hospitals, crash carts, and emergency kits.

Specifications

Directions

For use only by healthcare professionals in hospital or emergency settings.

1. Administration:
   • For acute ventricular arrhythmias: Inject 150 mg (one 3 mL vial) over 10 minutes.
   • This may be followed by a continuous infusion (as per ACLS guidelines and clinician instructions).
2. Preparation:
   • Inspect vials for clarity—use only if solution is clear and free from particulates.
   • Use aseptic technique for administration.
3. Monitoring:
   • Continuous ECG and vital signs monitoring are mandatory during and after infusion.
   • Dosage and infusion rate must be adjusted according to patient’s clinical response and institutional protocols.

Always consult the full prescribing information for detailed dosing and administration guidelines.

Side Effects

Common Side Effects:

• Hypotension (low blood pressure)
• Bradycardia (slow heart rate)
• Phlebitis (vein irritation at injection site)
• Nausea

Serious/Rare Side Effects:

• QT prolongation and risk of torsades de pointes (life-threatening arrhythmias)
• Severe hypotension or cardiac arrest
• Liver dysfunction (elevated liver enzymes, jaundice)
• Severe hypersensitivity reactions (rash, anaphylaxis, respiratory distress)

Immediately report and treat any severe or unusual reactions. Continuous monitoring is essential.

Warnings

• For IV Use Only: Not for intramuscular or subcutaneous administration.
• Hospital Setting Only: Use only in facilities where cardiac resuscitation and continuous monitoring are available.
• Not a First Choice for Mild Arrhythmias: Reserved for life-threatening or refractory cases only.
• Drug Interactions: May interact with other antiarrhythmics, QT-prolonging agents, and CYP3A inhibitors.
• Organ Toxicity: Potential for pulmonary, hepatic, and thyroid toxicity, especially with chronic exposure.
• Pregnancy & Lactation: Use only if clearly needed and benefits outweigh risks; not recommended during breastfeeding.

Why Choose Amiodarone HCl Injection 150 mg/3 mL by Mylan?

Amiodarone HCl Injection 150 mg/3 mL by Mylan (NDC: 67457-0153-03) provides high-impact, rapid response antiarrhythmic action when lives are on the line. Developed to the highest standards for hospital and emergency use, it’s the trusted choice of clinicians, pharmacists, and resuscitation teams nationwide.

Order Amiodarone HCl Injection 150 mg/3 mL Single Dose Vials (3 mL x 10/Box) by Mylan for uncompromising quality, rapid availability, and life-saving performance in critical cardiac emergencies.